News
Better For You Wellness Announces Replacement of Independent Director
Columbus, Ohio--(Newsfile Corp. - June 24, 2022) - Better For You Wellness, Inc. (OTCQB: BFYW) ("Better For You Wellness" or...
Rushnet, Inc Current Status Update on the Progress Towards heliosDX Spinout and Capital Raise Through Tier 2 Regulation A
ALPHARETTA, GA / ACCESSWIRE / June 24, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to provide this...
TeleQ Introduces Integration with PointClickCare’s EHR Platform to Mitigate Physician Shortage in a Post-Acute Care Setting
BRIDGEWATER, N.J.--(BUSINESS WIRE)--TeleQ (www.teleq.net) a virtual multispecialty physician group with a proprietary telehealth technology platform, is proud to announce the...
Innovaccer Joins the CARIN Alliance to Advance Access and Interoperability in the Healthcare Ecosystem
Innovaccer will participate as a member of the multisector alliance to advance healthcare data sharing, enabling consumers, patients, and caregivers...
Gemina Announces Filing of Prospectus Supplement
VANCOUVER, BC / ACCESSWIRE / June 24, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to...
Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies
HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology...
BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication. Bria-IMT™,...
Albireo Presents New Bylvay® (odevixibat) Data at Annual ESPGHAN Congress
Four presentations highlight newest data from landmark Phase 3 PEDFIC 1 and PEDFIC 2 trials, largest studies completed in PFICNew...
Memorial Hermann and Contessa Partner to Provide Patients New At-Home Care Options
This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative careHOUSTON and NASHVILLE, Tenn., June 24, 2022...
Artelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland
SOLANA BEACH, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
This Partnership Expands QHSLab’s Independent Practitioner Network, While Addressing Current Industry Pain Points. WEST PALM BEACH, FL, June 24, 2022...
Quotient Limited Announces Pricing of Underwritten Offering
JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today...
Daré Bioscience Announces Partial Adjournment of Annual Meeting of Stockholders to July 14, 2022
Meeting to be reconvened solely with respect to Proposal 5SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc....
Adverum Biotechnologies Granted Priority Medicines (PRIME) Designation by European Medicines Agency for ADVM-022 in Wet AMD
REDWOOD CITY, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting...